| Authors: |
Borowsky B; Novartis Pharmaceuticals Corp., East Hanover, NJ, USA. beth.borowsky@novartis.com., Ramos H; Novartis Pharmaceuticals Corp., East Hanover, NJ, USA., Caputo A; Novartis Pharma AG, Basel, Switzerland., Hartmann A; Novartis Pharma AG, Basel, Switzerland., Faller T; Novartis Pharma AG, Basel, Switzerland., Peters T; Novartis Pharma AG, Basel, Switzerland., Sui Y; Novartis Pharmaceuticals Corp., East Hanover, NJ, USA., Liu F; Novartis Pharmaceuticals Corp., East Hanover, NJ, USA., Meadowcroft M; Novartis Biomedical Research Inc., Cambridge, MA, USA., David OJ; Novartis Pharma AG, Basel, Switzerland., Laisney M; Novartis Pharma AG, Basel, Switzerland., Kinhikar A; Novartis Biomedical Research Inc., Cambridge, MA, USA., Marder KS; Columbia University Irving Medical Center, New York, NY, USA., Tabrizi SJ; Queen Square Institute of Neurology, University College London, London, UK., Landwehrmeyer GB; University of Ulm, Ulm, Germany., Leavitt BR; Centre for Molecular Medicine and Therapeutics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. |
